These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 10729739)

  • 1. Drug injectors and the cleaning of needles and syringes.
    Hughes RA
    Eur Addict Res; 2000 Mar; 6(1):20-30. PubMed ID: 10729739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illicit drug injectors' strategies for cleaning needles and syringes: findings from qualitative research.
    Hughes R
    Scand J Public Health; 2000 Jun; 28(2):158-60. PubMed ID: 10954144
    [No Abstract]   [Full Text] [Related]  

  • 3. Clean switch: the case for prison needle and syringe programs.
    Chu S
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):5-19. PubMed ID: 20225504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons.
    O'Sullivan BG; Levy MH; Dolan KA; Post JJ; Barton SG; Dwyer DE; Kaldor JM; Grulich AE
    Med J Aust; 2003 Jun; 178(11):546-9. PubMed ID: 12765501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
    Stark K; Herrmann U; Ehrhardt S; Bienzle U
    Epidemiol Infect; 2006 Aug; 134(4):814-9. PubMed ID: 16371183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of HIV among drug addicts in three French cities: implications for prevention.
    Ingold FR; Toussirt M
    Bull Narc; 1993; 45(1):117-34. PubMed ID: 8305902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Amsterdam needle and syringe exchange.
    Buning EC
    Int J Addict; 1991 Dec; 26(12):1303-11. PubMed ID: 1787023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing hepatitis C: what do positive injectors do?
    Carruthers SJ
    Drug Alcohol Rev; 2005 Mar; 24(2):193-8. PubMed ID: 16076589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; Barón A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringe and needle exchange programs: Part I.
    Schwartz RH
    South Med J; 1993 Mar; 86(3):318-22. PubMed ID: 8451672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower syringe sharing and re-use after syringe legalization in Rhode Island.
    Rich JD; Hogan JW; Wolf F; DeLong A; Zaller ND; Mehrotra M; Reinert S
    Drug Alcohol Depend; 2007 Jul; 89(2-3):292-7. PubMed ID: 17386980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
    Månsson AS; Moestrup T; Nordenfelt E; Widell A
    Scand J Infect Dis; 2000; 32(3):253-8. PubMed ID: 10879594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transmission of infectious diseases during imprisonment--results of a study and introduction of a model project for infection prevention in Lower Saxony].
    Keppler K; Stöver H
    Gesundheitswesen; 1999 Apr; 61(4):207-13. PubMed ID: 10408149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid assessment of injection practices in Cambodia, 2002.
    Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
    BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for hepatitis C transmission among non-needle/syringe sharing Sheffield drug injectors through the sharing of drug preparation paraphernalia.
    Green ST; Mohsen AH; McKendrick MW; Dawes Y; Prakasam SF; Walberg R; Schmid ML
    Commun Dis Public Health; 2001 Mar; 4(1):38-41. PubMed ID: 11467017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of risky injection practices associated with hepatitis B, hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire.
    Reynolds GL; Fisher DG; Napper LE
    J Addict Dis; 2012; 31(1):80-8. PubMed ID: 22356671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options for reducing HIV transmission related to the dead space in needles and syringes.
    Zule WA; Pande PG; Otiashvili D; Bobashev GV; Friedman SR; Gyarmathy VA; Des Jarlais DC
    Harm Reduct J; 2018 Jan; 15(1):3. PubMed ID: 29334973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.